Should pregnant women be included in phase IV clinical drug trials?

Gerald G. Briggs*, Janine E. Polifka, Katherine L. Wisner, Eric Gervais, Richard K. Miller, Anick Berard, Gideon Koren, Alicia Forinash, Craig V. Towers

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Fingerprint

Dive into the research topics of 'Should pregnant women be included in phase IV clinical drug trials?'. Together they form a unique fingerprint.

INIS

Pharmacology, Toxicology and Pharmaceutical Science